Cubist acquiring Optimer in a cash and contingent value right deal worth up to $801 million

Optimer Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Cubist Pharmaceuticals Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

$3,664.7m on 07/26/2013 [market cap]

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed